Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 1Phase 3 1Phase 2 1

Status

Completed 3Recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Endocrine 2

Conditions

Breast Neoplasms 1911Neoplasms 1531Prostatic Neoplasms 753Colorectal Neoplasms 715Lung Neoplasms 583Motor Activity 393Head and Neck Neoplasms 328Colonic Neoplasms 312Uterine Cervical Neoplasms 300Pain 248Pancreatic Neoplasms 246Anxiety Disorders 221Rectal Neoplasms 214Carcinoma, Hepatocellular 209Carcinoma, Non-Small-Cell Lung 206Fatigue 194Stomach Neoplasms 192Polycystic Ovary Syndrome 188Ovarian Neoplasms 186Precursor Cell Lymphoblastic Leukemia-Lymphoma 178Brain Neoplasms 169Depression 166Urinary Bladder Neoplasms 165Melanoma 163Neoplasm Metastasis 162Esophageal Neoplasms 140Multiple Myeloma 138Lymphoma 136Lymphoma, Follicular 128Obesity 127

Interventions

Radiofrequency Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Completed × Hyperaldosteronism × Clear all
NCT02756754 2026-05-04

ADERADHTA

University Hospital, Toulouse

Phase NA Completed
31 enrolled

ACTH Syndrome, Ectopic, Hyperaldosteronism

NCT01567111 2019-03-11

MIA

Helsinki University Central Hospital

Phase NA Completed
40 enrolled
Endocrine

Hyperaldosteronism, Adrenocortical Adenoma

NCT01676025 2017-10-06

PRA

Seoul National University Hospital

Phase NA Completed
83 enrolled
Endocrine

Adrenal incidentaloma, Adrenal Gland Diseases, Cushing Syndrome, Hyperaldosteronism, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡